Masimo receives FDA clearance for Stork baby monitoring system

Masimo announced FDA clearance of Stork, a baby monitoring system, for prescription use with healthy and sick babies 0-18 months of age. Stork is available at retailers nationwide as a non-medical device for general health and wellness purposes, Masimo said in a statement. With this clearance, Stork is now available for prescription use to continuously monitor babies at home as a medical device for healthy or sick babies.